On Cancer

and/or

26 Blog posts found

Feature

Tooling Up: New Technologies Drive Advances in Cancer Research and Treatment at MSK

MSK scientists and doctors have the most innovative tools at their disposal to make discoveries and develop better treatments.

Two researchers talking in the laboratory

Announcement

FDA Authorizes MSK-IMPACT Test for Analyzing Patient Tumors

The test, developed at MSK, looks for alterations in 468 genes that are seen in both common and rare cancers.

Gloved hand and magnifying glass on banded DNA sequences

Q & A

A Brief Guide to Breast Cancer Pathology and Second Opinions

Breast pathologist Edi Brogi explains what patients should know about breast cancer diagnosis, second opinions, and promising new developments in treating some of the most aggressive forms of the disease.

MSK Director of Breast Pathology Edi Brogi

At Work

What Does a Breast Cancer Pathologist Do? At Work with Hannah Wen

Learn about the role of pathologist Hannah Wen here at Memorial Sloan Kettering.

Memorial Sloan Kettering pathologist Hannah Wen

In the News

#ASCO17: Post-Conference Roundup of Themes and Trends

Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.

American Society of Clinical Oncology logo

In the Lab

Forensic Techniques Enable Study of Individual Breast Cancer Cells from MSK’s Archives

Analysis of long-preserved single cells on pathology slides aims to provide new clues about the genes that make breast cancer more aggressive.

Pathology slide showing DCIS and invasive cancer

In the Clinic

How Research Is Driving the Latest Treatments for Sarcoma

Surgeon and researcher Aimee Crago discusses the latest treatments for different types of soft tissue sarcoma, including liposarcoma and desmoid tumors.

MSK Surgeon Aimee Crago

In the Clinic

What’s New in Leiomyosarcoma?

In this Q&A, medical oncologist Martee Hensley discusses the diagnosis and treatment of leiomyosarcoma and other uterine sarcomas.

Leiomyosarcoma expert Martee Hensley

In the Clinic

Powerful Tumor DNA Test Has Guided Cancer Treatment for 10,000 MSK Patients

Learn how MSK’s powerful new tumor DNA test has helped guide treatment decisions for more than 10,000 people with advanced cancer.

Three scientists look up at ascreen showing genetic information about a tumor.

In the Lab

Rapid Results: MSK Researchers Link Genetic Mutation to Rare Bladder Cancer

MSK researchers have identified a genetic mutation that plays a central role in a rare, aggressive form of bladder cancer called plasmacytoid variant carcinoma.

David Solit